RPS-BLAST 2.2.26 [Sep-21-2011]

Database: CDD.v3.10 
           44,354 sequences; 10,937,602 total letters

Searching..................................................done

Query= psy6982
         (222 letters)



>gnl|CDD|222351 pfam13733, Glyco_transf_7N, N-terminal region of glycosyl
           transferase group 7.  This is the N-terminal half of a
           family of galactosyltransferases from a wide range of
           Metazoa with three related galactosyltransferases
           activities, all three of which are possessed by one
           sequence in some cases. EC:2.4.1.90, N-acetyllactosamine
           synthase; EC:2.4.1.38,
           Beta-N-acetylglucosaminyl-glycopeptide beta-1,4-
           galactosyltransferase; and EC:2.4.1.22 Lactose synthase.
           Note that N-acetyllactosamine synthase is a component of
           Lactose synthase along with alpha-lactalbumin, in the
           absence of alpha-lactalbumin EC:2.4.1.90 is the
           catalyzed reaction.
          Length = 136

 Score = 96.4 bits (240), Expect = 2e-25
 Identities = 43/94 (45%), Positives = 55/94 (58%), Gaps = 3/94 (3%)

Query: 88  CPVVPPNLQGALKIH-KRYRSLNQIEKELAPLELEPGGSHRPKSCIALFRVAIIVPYRDR 146
           CP   P L G + +      SL +I +      +EPGG ++P  C+   R AII+PYR R
Sbjct: 1   CPERSPLLVGPVSVSFSPVPSLAEIVENNT--HVEPGGRYKPAGCLPRSRTAIIIPYRAR 58

Query: 147 KPHLHLLLYNLHPMLVRQQIDYTIFIIEQASNRK 180
           + HL LLLY LHP L RQQ+ Y IF+IEQA N  
Sbjct: 59  EEHLRLLLYRLHPFLQRQQLAYGIFVIEQAGNGP 92


>gnl|CDD|132999 cd00899, b4GalT, Beta-4-Galactosyltransferase is involved in the
           formation of the poly-N-acetyllactosamine core
           structures present in glycoproteins and
           glycosphingolipids.  Beta-4-Galactosyltransferase
           transfers galactose from uridine diphosphogalactose to
           the terminal beta-N-acetylglucosamine residues, hereby
           forming the poly-N-acetyllactosamine core structures
           present in glycoproteins and glycosphingolipids. At
           least seven homologous beta-4-galactosyltransferase
           isoforms have been identified that use different types
           of glycoproteins and glycolipids as substrates. Of the
           seven identified members of the
           beta-1,4-galactosyltransferase subfamily (beta1,4-Gal-T1
           to -T7), b1,4-Gal-T1 is most characterized
           (biochemically). It is a Golgi-resident type II membrane
           enzyme with a cytoplasmic domain, membrane spanning
           region, and a stem region and catalytic domain facing
           the lumen.
          Length = 219

 Score = 78.8 bits (195), Expect = 4e-18
 Identities = 26/43 (60%), Positives = 33/43 (76%)

Query: 136 RVAIIVPYRDRKPHLHLLLYNLHPMLVRQQIDYTIFIIEQASN 178
           +VAIIVP+R+R  HL + L +LHP L RQQ+DY IF+IEQ  N
Sbjct: 3   KVAIIVPFRNRFEHLLIFLPHLHPFLQRQQLDYRIFVIEQVGN 45


>gnl|CDD|198184 cd09930, SH2_cSH2_p85_like, C-terminal Src homology 2 (cSH2) domain
           found in p85.  Phosphoinositide 3-kinases (PI3Ks) are
           essential for cell growth, migration, and survival.
           p110, the catalytic subunit, is composed of an
           adaptor-binding domain, a Ras-binding domain, a C2
           domain, a helical domain, and a kinase domain.  The
           regulatory unit is called p85 and is composed of an SH3
           domain, a RhoGap domain, a N-terminal SH2 (nSH2) domain,
           a inter SH2 (iSH2) domain, and C-terminal (cSH2) domain.
            There are 2 inhibitory interactions between p110alpha
           and p85 of P13K: 1) p85 nSH2 domain with the C2,
           helical, and kinase domains of p110alpha and 2) p85 iSH2
           domain with C2 domain of p110alpha. There are 3
           inhibitory interactions between p110beta and p85 of
           P13K: 1) p85 nSH2 domain with the C2, helical, and
           kinase domains of p110beta, 2) p85 iSH2 domain with C2
           domain of p110alpha, and 3) p85 cSH2 domain with the
           kinase domain of p110alpha. It is interesting to note
           that p110beta is oncogenic as a wild type protein while
           p110alpha lacks this ability. One explanation is the
           idea that the regulation of p110beta by p85 is unique
           because of the addition of inhibitory contacts from the
           cSH2 domain and the loss of contacts in the iSH2 domain.
           In general SH2 domains are involved in signal
           transduction. They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 104

 Score = 28.1 bits (63), Expect = 1.2
 Identities = 15/46 (32%), Positives = 23/46 (50%), Gaps = 7/46 (15%)

Query: 180 KRAGSTRVRAWWKSSAQILY-CSISCG---YHCTLQRSKTSFAFAA 221
           K  G+  +R    SS Q  Y CS+ C     HC + +++T + FA 
Sbjct: 25  KPDGTFLIRE---SSTQGCYACSVVCNGEVKHCVIYKTETGYGFAE 67


>gnl|CDD|237735 PRK14503, PRK14503, mannosyl-3-phosphoglycerate synthase;
           Provisional.
          Length = 393

 Score = 29.3 bits (66), Expect = 1.4
 Identities = 25/102 (24%), Positives = 40/102 (39%), Gaps = 29/102 (28%)

Query: 97  GALKIHKRYRSLNQIEKELAPLELEPGGSHRPKSCI----------ALFRVAIIVPYRDR 146
           GA++I++  + L          +L+ G    P   I           L R+AI+VP ++ 
Sbjct: 13  GAVRIYEVQKVL----------KLDSGREDVPAYTIRNVPREDLYDILGRMAIVVPVKNE 62

Query: 147 KPHLHLLLYNLHPMLVRQQIDYTIFIIEQASNRKRAGSTRVR 188
           +     LL       V + I +   II   SN KR    R +
Sbjct: 63  RLK---LLEG-----VLKGIPHECPII-VVSNSKREPPDRFK 95


>gnl|CDD|144140 pfam00434, VP7, Glycoprotein VP7. 
          Length = 326

 Score = 28.6 bits (64), Expect = 2.3
 Identities = 13/59 (22%), Positives = 31/59 (52%)

Query: 19 YKVLIIVVLALVLIEFTFSLLSETHNFYMHPFLTSINYTSPFMSSSIMYFNLTVQRNMD 77
          Y  ++  +++++L+ +    ++   ++ ++ FL  I   SPF S+     NL +  +MD
Sbjct: 6  YTTILTFLISIILLNYILKTITRIMDYIIYRFLLVIVVLSPFSSAQNYGINLPITGSMD 64


>gnl|CDD|227061 COG4717, COG4717, Uncharacterized conserved protein [Function
           unknown].
          Length = 984

 Score = 27.9 bits (62), Expect = 6.0
 Identities = 16/70 (22%), Positives = 28/70 (40%), Gaps = 10/70 (14%)

Query: 94  NLQGALKIHKRYRSLNQIEKELAPLELEPGGSHRPKSCIALFRVAIIVPYRDRKPHLHLL 153
            L+ A+++  R +   Q+E+EL     E           A F    ++    R+ HL   
Sbjct: 237 ALRDAVELWPRLQEWKQLEQELTRRREEL----------ATFPRDGVLRLEKREAHLQKT 286

Query: 154 LYNLHPMLVR 163
              +  +LVR
Sbjct: 287 EAEIDALLVR 296


>gnl|CDD|192303 pfam09488, Osmo_MPGsynth, Mannosyl-3-phosphoglycerate synthase
           (osmo_MPGsynth).  This family consists of examples of
           mannosyl-3-phosphoglycerate synthase (MPGS), which
           together with mannosyl-3-phosphoglycerate phosphatase
           (MPGP) EC:2.4.1.217, comprises a two-step pathway for
           mannosylglycerate biosynthesis. Mannosylglycerate is a
           compatible solute that tends to be restricted to extreme
           thermophiles of archaea and bacteria. Note that in
           Rhodothermus marinus, this pathway is one of two; the
           other is condensation of GDP-mannose with D-glycerate by
           mannosylglycerate synthase.
          Length = 381

 Score = 26.9 bits (60), Expect = 8.4
 Identities = 16/56 (28%), Positives = 29/56 (51%), Gaps = 3/56 (5%)

Query: 97  GALKIHKRYRSLNQIEKELAPLELEPGGSHRPKSCI--ALFRVAIIVPYRDRKPHL 150
           GA++IH+  R L +++     L   P   + P+  +   L ++AI+VP +D    L
Sbjct: 11  GAVRIHEVQRVL-ELDSGSTGLSGVPTIKNIPREELSDILGQMAIVVPVKDEDLKL 65


>gnl|CDD|220677 pfam10291, muHD, Muniscin C-terminal mu homology domain.  The
           muniscins are a family of endocytic adaptors that is
           conserved from yeast to humans.This C-terminal domain is
           structurally similar to mu homology domains, and is the
           region of the muniscin proteins involved in the
           interactions with the endocytic adaptor-scaffold
           proteins Ede1-eps15. This interaction influences
           muniscin localisation. The muniscins provide a combined
           adaptor-membrane-tubulation activity that is important
           for regulating endocytosis.
          Length = 251

 Score = 26.9 bits (60), Expect = 8.7
 Identities = 15/41 (36%), Positives = 21/41 (51%), Gaps = 5/41 (12%)

Query: 49  PFLTS--INYT---SPFMSSSIMYFNLTVQRNMDNTSTTGI 84
           P  TS  ++Y    SP  SSS++  NL V  N+D +  T  
Sbjct: 117 PHQTSLILDYKLNPSPASSSSLVLLNLVVSVNLDGSRVTSA 157


>gnl|CDD|236872 PRK11183, PRK11183, D-lactate dehydrogenase; Provisional.
          Length = 564

 Score = 27.1 bits (61), Expect = 8.9
 Identities = 14/29 (48%), Positives = 16/29 (55%), Gaps = 7/29 (24%)

Query: 107 SLNQIEKELAPLELEPG---GSHRPKSCI 132
           +L Q+EK L PL  EP    GS    SCI
Sbjct: 116 TLYQLEKALKPLGREPHSVIGS----SCI 140


  Database: CDD.v3.10
    Posted date:  Mar 20, 2013  7:55 AM
  Number of letters in database: 10,937,602
  Number of sequences in database:  44,354
  
Lambda     K      H
   0.327    0.137    0.416 

Gapped
Lambda     K      H
   0.267   0.0647    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 11,104,403
Number of extensions: 1029730
Number of successful extensions: 1220
Number of sequences better than 10.0: 1
Number of HSP's gapped: 1218
Number of HSP's successfully gapped: 22
Length of query: 222
Length of database: 10,937,602
Length adjustment: 93
Effective length of query: 129
Effective length of database: 6,812,680
Effective search space: 878835720
Effective search space used: 878835720
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 15 ( 7.1 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 40 (21.7 bits)
S2: 57 (25.9 bits)